<DOC>
<DOCNO>EP-0646593</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Corticoid-17,21-dicarboxylic acid ester, process for their production and medicaments containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P2900	C07J4300	C07J3100	C07J1700	C07J4300	A61K3157	A61K31573	C07J3300	C07J3100	C07J3300	A61K3157	C07J500	A61P1700	A61P2900	C07J7500	C07J500	A61P1700	C07J4100	C07J4100	C07J1700	C07J7500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	C07J	C07J	C07J	C07J	A61K	A61K	C07J	C07J	C07J	A61K	C07J	A61P	A61P	C07J	C07J	A61P	C07J	C07J	C07J	C07J	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P29	C07J43	C07J31	C07J17	C07J43	A61K31	A61K31	C07J33	C07J31	C07J33	A61K31	C07J5	A61P17	A61P29	C07J75	C07J5	A61P17	C07J41	C07J41	C07J17	C07J75	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Corticoid 17,21-dicarboxylic esters and corticoid 17-carboxylic esters 21-carbonic esters of the formula I 
<
IMAGE
>
  with     A equal to CHOH and CHClm CH2, C=0, 9(11) double bond;   Y equal to H, F, Cl;   Z equal to H, F, methyl,   R(1) equal to aryl, hetaryl;   R(2) equal to alkyl,   R(3) equal to H, methyl are described. They are obtained, inter alia, by reacting a compound of the formula II 
<
IMAGE
>
 in which R(5) is equal to OH, with an activated carboxylic acid of the formula III 
<
IMAGE
>
   They have very high local and topical antiinflammatory activity and show a very good ratio of local to systemic antiinflammatory effect. They are used inter alia as agents for treating inflammatory dermatoses.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ALPERMANN HANS-GEORG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BOHN MANFRED DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DUERCKHEIMER WALTER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
STACHE ULRICH DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ALPERMANN, HANS-GEORG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
BOHN, MANFRED, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
DUERCKHEIMER, WALTER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
STACHE, ULRICH, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A corticoid 17,21-dicarboxylic ester of the formula
I



in which:

A
is CHOH and CHCl in arbitrary steric arrangement, (CH
2
), C=O or 9(11) double bond;
Y
is hydrogen, fluorine or chlorine;
Z
is hydrogen, fluorine or methyl;
R(1)
is phenyl which is unsubstituted or is substituted by methylenedioxy, halogen,
alkyl, alkoxy, NO
2
, NH
2
 or CN;

[(C
1
-C
4
)-alkyl]
 
   saturated, straight-chain or branched by

further alkyl groups,

m
is 1;
R(2)
is phenyl or benzyl;
R(3)
is hydrogen or α- or β-methyl.
A compound as claimed in claim 1 which is
prednisolone 17-benzoate 21-phenylacetate or

betamethasone 17-benzoate 21-phenylacetate.
A process for preparing a compound I as claimed in
claim 1, wherein


a) a compound of the formula II


in which R(5) is OH and the remaining substituents
have the meanings given in claim 1,


a1) is reacted with an activated carboxylic acid
of the formula III, preferably a halide or

anhydride or azolide,

R(6)-CO-[(C
1
-C
4
)-alkyl]
m
-R(1)
 
in which:


m is 1, and
[(C
1
-C
4
)-alkyl] and R(1) have the meanings given in

claim 1, and
R(6) is Cl, Br, O[-CO-[(C
1
-C
4
)-alkyl]
m
-R(1)]
1
-,
-O-C(O)-CF
3
, or another activated acid
radical, or
a2) is reacted with a carboxylic acid of the
formula III itself, in which

R(6) is OH,

and the other substituents are given in formula
III,

in the presence of water-eliminating reagents
(DCCI, etc.),

or wherein
b) compounds of the formula II

 
in which R(5) is Br, I, or a sulfonic aryl ester

group or sulfonic alkyl ester group, and the other
substituents have the meaning given in formula I,

are reacted with a salt, preferably a K or Na salt
or a trialkylammonium salt, of a carboxylic acid

of the formula III,

R(6)-CO-[(C
1
-C
4
)-alkyl]
m
-R(1)

in which

R(6)
is -[O
-
Me
+
],

and the other substituents have the meanings given
in formula III,

Me preferably being the cation of an alkali metal
salt or of a trialkylammonium salt.
A pharmaceutical which has an effective content of
a compound I as claimed in claim 1.
Use of a compound I as claimed in claim 1 for preparing
a pharmaceutical for treating dermatoses.
</CLAIMS>
</TEXT>
</DOC>
